Johannes Czernin, MD, editor-in-chief of The Journal of Nuclear Medicine (JNM), and his associate editors and editorial board announced in April the articles chosen as the most outstanding contributions to the journal appearing in 2021. The JNM Editors’ Choice Awards are presented in June as part of the SNMMI Annual Meeting. Awarded articles are selected by the associate editors by anonymous vote. “Along with my colleagues on the editorial board, I am pleased to recognize these contributions as outstanding clinical and preclinical research,” said Czernin. “Submissions to JNM remained strong and of extraordinarily high quality in 2021. Our awardees represent the cutting-edge clinical research activities that are advancing nuclear medicine, molecular imaging, and theranostics to the benefit of patients.”
In the category of Best Clinical Article, the award went to Manuel Röhrich, from University Hospital Heidelberg (Germany), and coauthors Patrick Naumann, Frederik L. Giesel, Peter L. Choyke, Fabian Staudinger, Annika Wefers, Dawn P. Liew, Clemens Kratochwil, Hendrik Rathke, Jakob Liermann, Klaus Herfarth, Dirk Jäger, Jürgen Debus, Uwe Haberkorn, Matthias Lang, and Stefan A. Koerber for “Impact of 68Ga-FAPI PET/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas” (J Nucl Med. 2021;62:779–786). This contribution was also named the best overall article in JNM for 2021.
Mark G. MacAskill, from the University/BHF Centre for Cardiovascular Science at the University of Edinburgh (UK), and coauthors Agne Stadulyte, Lewis Williams, Timaeus E.F. Morgan, Nikki L. Sloan, Carlos J. Alcaide-Corral, Tashfeen Walton, Catriona Wimberley, Chis-Anne McKenzie, Nick Spath, William Mungall, Ralph BouHaidar, Marc R. Dweck, Gillian A. Gray, David E. Newby, Christophe Lucatelli, Andrew Sutherland, Sally L. Pimlott, and Adriana A.S. Tavares were the recipients of the award for Best Basic Science Article for “Quantification of macrophage-driven inflammation during myocardial infarction with 18F-LW223, a novel TSPO radiotracer with binding independent of the rs6971 human polymorphism” (J Nucl Med. 2021;62:536–544).
“The associate editors and I are grateful for these remarkable contributions,” said Czernin. “These and similar efforts ensure that JNM remains the journal of choice for publishing clinical, basic, and translational research in nuclear medicine, molecular imaging, radiopharmaceutical therapy, and theranostics.”
- © 2022 by the Society of Nuclear Medicine and Molecular Imaging.